EGRX - Eagle Pharmaceuticals Inc. (EGRX) CEO Scott Tariff on Q3 2021 Results - Earnings Call Transcript

Eagle Pharmaceuticals, Inc. (EGRX) Q3 2021 Earnings Conference Call November 9, 2021, 08:30 AM ET Company Participants Lisa Wilson - Investor Relations Scott Tariff - Chief Executive Officer Brian Cahill - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald David Amsellem - Piper Sandler Tim Lugo - William Blair Presentation Operator Good morning everyone. My name is Ashley, and I will be your conference Operator today. At this time, I would like to welcome everyone to Eagle Pharmaceuticals' Third Quarter 2021 Financial Results Call. All lines have been placed on mute to prevent any background noise. After the speakers remarks, there will be a question and answers period. [Operator Instructions]. As a reminder, this conference call is being recorded today, November 09, 2021. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. Please go ahead. Lisa Wilson

For further details see:

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tariff on Q3 2021 Results - Earnings Call Transcript